Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Subcommittee recommendation,Crisantaspase (Erwinia L-asparaginase),"Acute lymphoblastic leukemia, allergic to L-asparaginase",Crisantaspase (Erwinia L-asparaginase),Recommended for decline,Hospital,Oncology Agents and Immunosuppressants
